Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             49 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Afatinib in NSCLC harbouring EGFR mutations de Marinis, Filippo
2014
15 4 p. e148-e149
nvt p.
artikel
2 A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group Hall, Jacqueline Anne
2014
15 4 p. e184-e193
nvt p.
artikel
3 Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis Höckel, Michael
2014
15 4 p. 445-456
12 p.
artikel
4 Atypical Spitz tumours and sentinel lymph node biopsy: a systematic review Lallas, Aimilios
2014
15 4 p. e178-e183
nvt p.
artikel
5 Atypical Spitz tumours and sentinel lymph nodes Duncan, Lyn McDivitt
2014
15 4 p. 377-378
2 p.
artikel
6 Baby Bear Weaver, Meaghann Shaw
2014
15 4 p. 383-384
2 p.
artikel
7 Bevacizumab for advanced cervical cancer Sharma, Sharan
2014
15 4 p. e155-
1 p.
artikel
8 Biomarker for fibrolamellar hepatocellular carcinoma Benmaamar, Ramla
2014
15 4 p. e156-
1 p.
artikel
9 Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial Pignata, Sandro
2014
15 4 p. 396-405
10 p.
artikel
10 Circulating tumour cells: telling the truth about metastasis Cristofanilli, Massimo
2014
15 4 p. 365-366
2 p.
artikel
11 Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data Bidard, François-Clément
2014
15 4 p. 406-414
9 p.
artikel
12 Community experience of vemurafenib for BRAF V600 melanoma Hersey, Peter
2014
15 4 p. 369-370
2 p.
artikel
13 Complications of prostate cancer treatment Bece, Andrej
2014
15 4 p. e149-e150
nvt p.
artikel
14 Complications of prostate cancer treatment Chen, Ronald C
2014
15 4 p. e150-
1 p.
artikel
15 Complications of prostate cancer treatment Linton, Kate D
2014
15 4 p. e150-e151
nvt p.
artikel
16 Complications of prostate cancer treatment Halperin, Ross
2014
15 4 p. e151-e152
nvt p.
artikel
17 Complications of prostate cancer treatment – Author's reply Nam, Robert
2014
15 4 p. e152-e153
nvt p.
artikel
18 Correction to Lancet Oncol 2013; 14: 1205 2014
15 4 p. e154-
1 p.
artikel
19 Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial Judson, Ian
2014
15 4 p. 415-423
9 p.
artikel
20 Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial Goss, Paul E
2014
15 4 p. 474-482
9 p.
artikel
21 Epigenetics, opium, and cancer Mahmoodpoor, Ata
2014
15 4 p. e153-
1 p.
artikel
22 Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial Dearnaley, David P
2014
15 4 p. 464-473
10 p.
artikel
23 Fertility preservation and consent The Lancet Oncology,
2014
15 4 p. 361-
1 p.
artikel
24 Follicular lymphoma: watch and wait is watch and worry Ansell, Stephen M
2014
15 4 p. 368-369
2 p.
artikel
25 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial Hoskin, Peter J
2014
15 4 p. 457-463
7 p.
artikel
26 Increase of thyroid cancer in children from Fukushima? Mayor, Susan
2014
15 4 p. e158-
1 p.
artikel
27 International Cancer Control Partnership Sullivan, Richard
2014
15 4 p. 385-386
2 p.
artikel
28 NICE guidance on pixantrone monotherapy for multiply relapsed or refractory aggressive non-Hodgkin lymphoma Landells, Linda J
2014
15 4 p. 381-382
2 p.
artikel
29 One step forward, two steps back Benjamin, Robert S
2014
15 4 p. 366-367
2 p.
artikel
30 Oophorectomy in women with BRCA1 or BRCA2 mutations Burki, Talha Khan
2014
15 4 p. e156-
1 p.
artikel
31 Palliative chemotherapy leads to more deaths away from home Tanday, Sanjay
2014
15 4 p. e157-
1 p.
artikel
32 Quality of life as a primary endpoint in ovarian cancer trials Mahner, Sven
2014
15 4 p. 363-364
2 p.
artikel
33 Radiotherapy for indolent lymphomas: how much is enough? Specht, Lena
2014
15 4 p. 372-374
3 p.
artikel
34 Radiotherapy for renal-cell carcinoma De Meerleer, Gert
2014
15 4 p. e170-e177
nvt p.
artikel
35 Refining insight into cervical cancer progression Sakuragi, Noriaki
2014
15 4 p. 371-372
2 p.
artikel
36 Risk of CNS dissemination in extranodal lymphomas Ferreri, Andrés J M
2014
15 4 p. e159-e169
nvt p.
artikel
37 Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial Ardeshna, Kirit M
2014
15 4 p. 424-435
12 p.
artikel
38 Secondary thyroid tumours and mortality Mayor, Susan
2014
15 4 p. e155-
1 p.
artikel
39 SGO not soft on morcellation: risks and benefits must be weighed Goff, Barbara A
2014
15 4 p. e148-
1 p.
artikel
40 Stereotactic radiosurgery for more than four brain metastases Lo, Simon S
2014
15 4 p. 362-363
2 p.
artikel
41 Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study Yamamoto, Masaaki
2014
15 4 p. 387-395
9 p.
artikel
42 Surgery versus radiotherapy for prostate cancer Burki, Talha Khan
2014
15 4 p. e157-
1 p.
artikel
43 Survey finds barriers to palliative care at home Burki, Talha Khan
2014
15 4 p. e158-
1 p.
artikel
44 The bone substudy of MA.27: does bone make a difference? Mathew, Aju
2014
15 4 p. 375-377
3 p.
artikel
45 The Firefly Project Penny, Helen
2014
15 4 p. 384-385
2 p.
artikel
46 The need to expand global access to radiotherapy Rodin, Danielle
2014
15 4 p. 378-380
3 p.
artikel
47 The value of randomised trials for prostate cancer management Loblaw, Andrew
2014
15 4 p. 374-375
2 p.
artikel
48 Vemurafenib in patients with BRAF V600 mutated metastatic melanoma: an open-label, multicentre, safety study Larkin, James
2014
15 4 p. 436-444
9 p.
artikel
49 When Hope Whispers Coburn, Cassie
2014
15 4 p. 385-
1 p.
artikel
                             49 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland